Your account is not claimed yet. You can sign up with ORCID to claim your account.

James John Ashton (James J Ashton, J J Ashton)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 18

Top Venues

Archives of disease in childhood

Alimentary pharmacology & therapeutics

Frontline gastroenterology

Archives of disease in childhood. Fetal and neonatal edition

This page only lists publications with an associated author ORCID identifier.

Publications

James John Ashton, Robert Mark Beattie
Inflammatory bowel disease: recent developments. Archives of disease in childhood (2023)
Marcus Karl-Heinz Auth, James John Ashton, Kelsey D J Jones, Astor Rodrigues, Dhamyanthi Thangarajah, David Devadason, Gemma Lee, Mashhood Ayaz, Huey Miin Lee, Jochen Kammermeier, null null
Variation in access and prescription of vedolizumab and ustekinumab in paediatric patients with inflammatory bowel disease: a UK-wide study. Archives of disease in childhood (2023)
James John Ashton, Kouros Driscoll, Joanna Himsworth, Robert Mark Beattie, Akshay Batra
Time to normalisation of tissue transglutaminase in paediatric coeliac disease is dependent on initial titre and half of patients will normalise within 12 months. Archives of disease in childhood 107 (7) (2022)
James John Ashton, Johanne Brooks-Warburton, Patrick B Allen, Tony C Tham, Sami Hoque, Nicholas Alexander Kennedy, Anjan Dhar, Shaji Sebastian
The importance of high-quality 'big data' in the application of artificial intelligence in inflammatory bowel disease. Frontline gastroenterology 14 (3) (2022)
James John Ashton, Sarah Ennis, Robert Mark Beattie
Infliximab at diagnosis: moving towards personalisation in paediatric inflammatory bowel disease. Gut 71 (1) (2021)
Claire Barnes, James John Ashton, Florina Borca, Mick Cullen, Dawn-Marie Walker, Robert Mark Beattie
Children and young people with inflammatory bowel disease attend less school than their healthy peers. Archives of disease in childhood 105 (7) (2020)
Robert Mark Beattie, James John Ashton, Ian D Penman
COVID-19 and the gastrointestinal tract: emerging clinical data. Frontline gastroenterology 11 (4) (2020)
James John Ashton, Zachary Green, Aneurin Young, Florina Borca, Tracy Coelho, Akshay Batra, Nadeem A Afzal, Sarah Ennis, Mark John Johnson, Robert Mark Beattie
Growth failure is rare in a contemporary cohort of paediatric inflammatory bowel disease patients. Acta paediatrica (Oslo, Norway : 1992) 110 (1) (2020)
James John Ashton, Jochen Kammermeier, Christine Spray, Richard K Russell, Richard Hansen, Lucy J Howarth, Franco Torrente, Protima Deb, Elizabeth Renji, Rafeeq Muhammed, Thankam Paul, Fevronia Kiparissi, Jenny Epstein, Maureen Lawson, Ben Hope, Veena Zamvar, Priya Narula, Ahmed Kadir, David Devadason, Hemant Bhavsar, Robert Mark Beattie
Impact of COVID-19 on diagnosis and management of paediatric inflammatory bowel disease during lockdown: a UK nationwide study. Archives of disease in childhood 105 (12) (2020)
James John Ashton, Robert Mark Beattie
Letter: anti-TNF therapy and intestinal resections in Crohn's disease-are we just delaying the inevitable? Alimentary pharmacology & therapeutics 50 (7) (2020)
Robert Mark Beattie, James John Ashton, Philip D J Dunne
COVID-19 and the gastrointestinal tract: recent data. Frontline gastroenterology 11 (5) (2020)
Aneurin Young, Edward Thomas Andrews, James John Ashton, Freya Pearson, Robert Mark Beattie, Mark John Johnson
Generating longitudinal growth charts from preterm infants fed to current recommendations. Archives of disease in childhood. Fetal and neonatal edition 105 (6) (2020)
James John Ashton, Akshay Batra, Tracy A F Coelho, Nadeem A Afzal, R Mark Beattie
Challenges in chronic paediatric disease during the COVID-19 pandemic: diagnosis and management of inflammatory bowel disease in children. Archives of disease in childhood 105 (7) (2020)
James John Ashton, Enrico Mossotto, R Mark Beattie, Sarah Ennis
TTC7A Variants Previously Described to Cause Enteropathy Are Observed on a Single Haplotype and Appear Non-pathogenic in Pediatric Inflammatory Bowel Disease Patients. Journal of clinical immunology 40 (1) (2019)
James John Ashton, Florina Borca, Enrico Mossotto, Tracy Coelho, Akshay Batra, Nadeem A Afzal, Hang T T Phan, Michael Stanton, Sarah Ennis, Robert Mark Beattie
Increased prevalence of anti-TNF therapy in paediatric inflammatory bowel disease is associated with a decline in surgical resections during childhood. Alimentary pharmacology & therapeutics 49 (4) (2019)
James John Ashton, Katy Latham, Robert Mark Beattie, Sarah Ennis
Review article: the genetics of the human leucocyte antigen region in inflammatory bowel disease. Alimentary pharmacology & therapeutics 50 (8) (2019)
Aneurin Young, Edward T Andrews, James John Ashton, Freya Pearson, R Mark Beattie, Mark John Johnson
'Catch-up' growth of infants with IUGR does not significantly contribute to the whole-cohort weight gain pattern. Archives of disease in childhood. Fetal and neonatal edition 104 (6) (2019)
J Gavin, Luise V Marino, James John Ashton, R M Beattie
Patient, parent and professional perception of the use of maintenance enteral nutrition in Paediatric Crohn's Disease. Acta paediatrica (Oslo, Norway : 1992) 107 (12) (2018)

James John Ashton.css-eqlu8i{font-size:small;padding-left:4px;} (James J Ashton, J J Ashton)

Publication Activity (10 Years)

Top Topics

Top Venues

James John Ashton (James J Ashton, J J Ashton)